JD Health announces leadership changes, new CEO appointed

JD Health International Inc. has announced a reshuffling of its board of directors and the composition of its remuneration committee. Enlin Jin will resign as an executive director, chief executive officer, member of the remuneration committee, and authorized representative, effective September 29, 2025, to dedicate more time to his family. Concurrently, Qingqing Yi will step down as a non-executive director, effective September 30, 2025, due to other business commitments. Both directors confirmed no disagreement with the board regarding their resignations.

In conjunction with these changes, Dong Cao has been appointed as an executive director, chief executive officer, and authorized representative, effective September 29, 2025. Cao, aged 49, brings extensive experience from his tenure within the JD Group, including roles as head of various financial departments and chief financial officer of JD Health, as well as executive director and chief executive officer of JINGDONG Property, Inc. He holds professional certifications as a certified internal auditor and a certified public accountant.

Following the resignations, the remuneration committee will see Xingyao Chen appointed as a new member, effective September 29, 2025. The board now comprises Dong Cao as the executive director; Richard Qiangdong Liu and Qingqing Yi as non-executive directors; and Ling Li, Jiyu Zhang, Xingyao Chen, Ying Wu, and Professor George Lau as independent non-executive directors.